Pharmigene, Inc. (TPEX:7595)
Taiwan · Delayed Price · Currency is TWD 11.45
0.00 (0.00%)
Jul 11, 2025, 9:09 AM CST
Pharmigene Revenue
In the year 2024, Pharmigene had annual revenue of 116.53M TWD, down -12.19%. Pharmigene had revenue of 68.68M in the half year ending December 31, 2024, a decrease of -12.80%.
Revenue
116.53M
Revenue Growth
-12.19%
P/S Ratio
4.96
Revenue / Employee
n/a
Employees
n/a
Market Cap
577.82M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 40.47M |
| PharmaEssentia | 11.34B |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 117.33M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |
| Lumosa Therapeutics | 43.59M |